Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

42.40
Delayed Data
As of Sep 23
 +1.53 / +3.74%
Today’s Change
22.41
Today|||52-Week Range
59.96
-21.17%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close40.87
Today’s open40.87
Day’s range40.87 - 42.83
Volume589,622
Average volume (3 months)439,717
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-171.96%
Earnings growth (this year)-8.93%
Earnings growth (next 5 years)--
Revenue growth (last year)-84.17%
P/E ratioNM
Price/Sales21,235.50
Price/Book3.84

Competitors

 Today’s
change
Today’s
% change
LXRXLexicon Pharmaceutic...-0.19-1.01%
TBPHTheravance Biopharma...-0.79-2.16%
IPXLImpax Laboratories I...+0.05+0.19%
ALDRAlder Biopharmaceuti...-0.33-0.96%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.86
Annual revenue (last year)$91.4K
Annual profit (last year)-$104.8M
Net profit margin-114,698.50%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts

Search for Jobs